Primary or Salvage Immune Tolerance Induction in Patients with Hemophilia A with Inhibitors Utilizing Alphanate®, Factor VIII/ von Willebrand Factor Complex (Human)

Retrospective chart review study: Evaluate the rates of success, partial success and failure among hemophilia patients with inhibitors who received alphante as a part of either a primary or rescue ITI protocol.

Hematology (Blood)
Peter Kouides, MD
Laura Braggins
(585) 922-5006